Letko, Brosseau & Associates’s Lyra Therapeutics LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-638
Closed -$8.83K 106
2024
Q2
$8.83K Hold
638
﹤0.01% 104
2024
Q1
$198K Hold
638
﹤0.01% 95
2023
Q4
$167K Hold
638
﹤0.01% 89
2023
Q3
$125K Hold
638
﹤0.01% 91
2023
Q2
$131K Buy
+638
New +$131K ﹤0.01% 91